Ascend Wellness Holdings (AAWH) Other Non Operating Income (2020 - 2026)
Ascend Wellness Holdings' (AAWH) quarterly Other Non Operating Income came in at $121000.0 in Q1 2026, down 74.63% year-on-year from $477000.0 in Q1 2025, and down 35.98% quarter-over-quarter from $189000.0 in Q4 2025.
Ascend Wellness Holdings (AAWH) Other Non Operating Income (2020 - 2026) Analysis & Trends
Ascend Wellness Holdings' Other Non Operating Income history runs 7 years deep, the most recent figure standing at $121000.0 for Q1 2026.
- On a quarterly basis, Other Non Operating Income fell 74.63% year-over-year to $121000.0 in Q1 2026; TTM through Mar 2026 was $1.1 million, a 29.86% increase from a year earlier, with the FY2025 full-year figure at $1.5 million, up 110.89% from the prior year.
- Other Non Operating Income eased to $121000.0 in Q1 2026 per AAWH's latest filing, from $189000.0 in the prior quarter.
- Across five years, Other Non Operating Income topped out at $24.0 million in Q2 2023 and bottomed at -$391000.0 in Q4 2024.
- The 5-year median for Other Non Operating Income is $310000.0 (2024), against an average of $1.7 million.
- Across the five-year window, Other Non Operating Income surged 15823.18% in 2023 and plunged 161.87% in 2024, its largest moves.
- Year by year, Other Non Operating Income stood at $229000.0 in 2022, then soared by 175.98% to $632000.0 in 2023, then plunged by 161.87% to -$391000.0 in 2024, then soared by 148.34% to $189000.0 in 2025, then plunged by 35.98% to $121000.0 in 2026.
- Per Business Quant, the three latest AAWH Other Non Operating Income figures stand at $121000.0 (Q1 2026), $189000.0 (Q4 2025), and $341000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 88.88 Bn | 87.01 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.92 Bn | 32.18 Bn | 1.97 Bn |
| 3 | Zoetis | 32.31 Bn | 30.37 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.54 Bn | 23.48 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.07 Bn | 20.91 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 20.53 Bn | 20.53 Bn | - |
| 7 | Viatris | 20.27 Bn | 18.47 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.92 Bn | 16.61 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.61 Bn | 12.18 Bn | 785.00 Mn |
| 10 | Ascend Wellness Holdings | 77.94 Mn | 17.02 Mn | 44.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 121,000.00 |
| Dec 31, 2025 | 189,000.00 |
| Sep 30, 2025 | 341,000.00 |
| Jun 30, 2025 | 484,000.00 |
| Mar 31, 2025 | 477,000.00 |
| Dec 31, 2024 | -391,000.00 |
| Sep 30, 2024 | 409,000.00 |
| Jun 30, 2024 | 379,000.00 |
| Mar 31, 2024 | 310,000.00 |
| Dec 31, 2023 | 632,000.00 |
| Sep 30, 2023 | 902,000.00 |
| Jun 30, 2023 | 24.04 Mn |
| Mar 31, 2023 | 265,000.00 |
| Dec 31, 2022 | 229,000.00 |
| Sep 30, 2022 | 273,000.00 |
| Jun 30, 2022 | 151,000.00 |
| Mar 31, 2022 | 103,000.00 |
| Dec 31, 2021 | 50,000.00 |
| Sep 30, 2021 | 44,000.00 |
| Jun 30, 2021 | 82,000.00 |